Dependency of Direct Pathway CD4+ T Cells on CD40-CD154 Costimulation Is Determined by Nature and Microenvironment of Primary Contact with Alloantigen

Journal of Immunology

Volumn 172, Issue 4, 2004, Pages 2163-2170

  Van Maurik, Andre ^a   Fazekas De St Groth, Barbara ^b   Wood, Kathryn J ^a   Jones, Nick D ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CENTENARY INSTITUTE   (Australia)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; H2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADOPTIVE TRANSFER; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; GRAFT SURVIVAL; HEART GRAFT; IN VIVO STUDY; LEUKOCYTE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

EID: 0842343441     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.4.2163     Document Type: Article

References (54)

1. Bretscher, P., and M. Cohn. 1970. A theory of self-nonself discrimination. Science 169:1042.
2. Lafferty, K. J., S. J. Prowse, and C. J. Simeonovic. 1983. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu. Rev. Immunol. 1:143.
3. Janeway, C. A. J., and K. Bottomly. 1994. Signals and signs for lymphocyte responses. Cell 76:275.
4. Jenkins, M. K., D. M. Pardoll, J. Mizuguchi, T. M. Chused, and R. H. Schwartz. 1987. Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones. Proc. Natl. Acad. Sci. USA 84:5409.
5. Schwartz, R. H. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1349.
6. Schwartz, R. H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71:1065.
7. Foy, T. M., J. D. Laman, J. A. Ledbetter, A. Aruffo, E. Claassen, and R. J. Noelle. 1994. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180:157.
8. Grewal, I. S., J. Xu, and R. A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:612.
9. Parker, D. C., D. L. Greiner, N. E. Phillips, M. C. Appel, A. W. Steele, F. H. Durie, R. J. Noelle, J. P. Mordes, and A. A. Rossini. 1995. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc. Natl. Acad. Sci. USA 92:9560.
10. Larsen, C. P., D. Z. Alexander, D. Hollenbaugh, E. T. Elwood, S. C. Ritchie, A. Aruffo, R. Hendrix, and T. C. Pearson. 1996. CD40-gp39 interactions play a critical role during allograft rejection: suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 61:4.
11. Hancock. W. W., M. H. Sayegh, X. G. Zheng, R. Peach, P. S. Linsley, and L. A. Turka. 1996. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc. Natl. Acad. Sci. USA 93:13967.
12. Kirk, A. D., D. M. Harlan, N. N. Armstrong, T. A. Davis, Y. Dong, G. S. Gray, X. Hong, D. Thomas, J. H. J. Fechner, and S. J. Knechtle. 1997. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA 94:8789.
13. Kenyon, N. S., M. Chatzipetrou, M. Masetti, A. Ranuncoli, M. Oliveira, J. L. Wagner, A. D. Kirk, D. M. Harlan, L. C. Burkly, and C. Ricordi. 1999. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc. Natl. Acad. Sci. USA 96:8132.
14. + T cells play a critical role in costimulation blockade-resistant allograft rejection. J. Clin. Invest. 104:1715.
15. + T cell tolerance and linked suppression. J. Immunol. 163:4805.
16. + T cells can trigger allograft rejection. J. Immunol. 165:1111.
17. Williams, M. A., J. Trambley, J. Ha, A. B. Adams, M. M. Durham, P. Rees, S. R. Cowan, T. C. Pearson, and C. P. Larsen. 2000. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts. J. Immunol. 165:6849.
18. Iwakoshi, N. N., T. G. Markees, N. Turgeon, T. Thornley, A. Cuthbert, J. Leif, N. E. Phillips, J. P. Mordes, D. L. Greiner, and A. A. Rossini. 2001. Skin allograft maintenance in a new synchimeric model system of tolerance. J. Immunol. 167:6623.
19. + T cells. Transplantation 70:955.
20. + T cells in vivo. Transplantation 72:1286.
21. Yamada, A., A. Chandraker, T. M. Laufer, A. J. Gerth, M. H. Sayegh, and H. Auchincloss, Jr. 2001. Recipient MHC class 11 expression required to achieve long-term survival of murine cardiac allografts after costimulatory blockade. J. Immunol. 167:5522.
22. Van Maurik, A., K. J. Wood, and N. D. Jones. 2002. Impact of both donor and recipient strains on cardiac allograft survival after blockade of the CD40-CD154 costimulatory pathway. Transplantation 74:740.
23. Rulifson, I. C., G. L. Szot, E. Palmer, and J. A. Bluestone. 2002. Inability to induce tolerance through direct antigen presentation. Am. J. Transplant. 2:510.
24. + T cells and prolonged graft survival in a CTLA4-dependent manner. J. Immunol. 164:512.
25. Sponaas, A. M., P. D. Tomlinson, J. Antoniou, N. Auphan, C. Langlet, B. Malissen, A. M. Schmitt-Verhulst, and A. L. Mellor. 1994. Induction of tolerance to self MHC class I molecules expressed under the control of milk protein or β-globulin gene promoters. Int. Immunol. 6:227.
26. Fazekas de St. Groth, B., P. A. Patten, W. Y. Ho, E. P. Rock, and M. M. Davis. 1992. An analysis of T cell receptor-ligand interaction using a transgenic antigen model for T cell tolerance and T cell receptor mutagenesis. In Molecular Mechanisms of Immunological Self-Recognition. Academic Press, San Diego, p. 123.
27. Corry, R. J., H. J. Winn, and P. S. Russell. 1973. Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 16:343.
28. Peto, R., P. C. Pik, P. Armitage, D. R. Cox, S. V. Howard, N. Mantal, K. M. Pherson, J. Peto, and D. G. Smith. 1977. Design and analysis of randomized clinical trials which require prolonged observation of each patient. II Analysis and examples. Br. J. Cancer 35:1.
29. + T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J. Immunol. 169:5401.
30. Wagoner, L. E., L. Zhao, D. K. Bishop, S. Chan, S. Xu, and W. H. Barry. 1996. Lysis of adult ventricular myocytes by cells infiltrating rejecting murine cardiac allografts. Circulation 93:111.
31. Wells, A. D., X. C. Li, Y. Li, M. C. Walsh, X. X. Zheng, Z. Wu, G. Nunez, A. Tang, M. Sayegh, W. W. Hancock, et al. 1999. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat. Med. 5:1303.
32. + regulatory cells prevent graft rejection: CTLA-4 and IL-10 dependent immunoregulation of alloresponses. J. Immunol. 168:1080.
33. Bushell, A., M. Niimi, P. J. Morris, and K. J. Wood. 1999. Evidence for immune regulation in the induction of transplantation tolerance: a conditional but limited role for IL-4. J. Immunol. 162:1359.
34. Li, Y., X. C. Li, X. X. Zheng, A. D. Wells, L. A. Turka, and T. B. Strom. 1999. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat. Med. 5:1298.
35. Zheng, X. X., T. G. Markees, W. W. Hancock, Y. Li, D. L. Greiner, X. C. Li, J. P. Mordes, M. H. Sayegh, A. A. Rossini, and T. B. Strom. 1999. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment. J. Immunol. 162:4983.
36. + T cells, interferon-γ, and CTLA4. J. Clin. Invest. 101:2446.
37. Graca, L., K. Honey, E. Adams, S. P. Cobbold, and H. Waldmann. 2000. Anti-CD154 therapeutic antibodies induce infectious transplantation tolerance. J. Immunol. 165:4783.
38. + T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. J. Immunol. 158:29.
39. Li, X. C., Y. Li, I. Dodge, A. D. Wells, X. X. Zheng, L. A. Turka, and T. B. Strom. 1999. Induction of allograft tolerance in the absence of Fas-mediated apoptosis. J. Immunol. 163:2500.
40. Sanchez-Fueyo, A., C. Domenig, T. B. Strom, and X. X. Zheng. 2002. The complement dependent cytotoxicity (CDC) immune effector mechanism contributes to anti-CD154 induced immunosuppression. Transplantation 74:898.
41. Bachmann, M. F., B. R. Wong, R. Josien, R. M. Steinman, A. Oxenius, and Y. Choi. 1999. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation. J. Exp. Med. 189:1025.
42. Lu, L., W. Li, C. Zhong, S. Qian, J. J. Fung, A. W. Thomson, and T. E. Starzl. 1999. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Transplantation 68:747.
43. Lechler, R. L. and J. R. Batchelor. 1982. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med. 155:31.
44. Lechler, R., W. Fai Ng, and R. M. Steinman. 2001. Dendritic cells in transplantation: friend or foe? Immunity 14:357.
45. Buhlmann, J. E., T. M. Foy, A. Aruffo, K. M. Crassi, J. A. Ledbetter, W. R. Green, J. C. Xu, L. Shultz, D. Roopesian, and R. A. e. a. Flavell. 1995. In the absence of a CD40 signal, B cells are tolerogenic. Immunity 2:645.
46. Niimi, M., T. C. Pearson, C. P. Larsen, D. Z. Alexander, D. Hollenbaugh, A. Aruffo, P. S. Linsley, E. Thomas, K. Campbell, W. C. Fanslow, et al. 1998. The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo. J. Immunol. 161:5331.
47. + T cell responses to CD40-deficient APCs: defects in proliferation and negative selection apply only with B cells as APCs. J. Immunol. 163:5250.
48. Evans, D. E., M. W. Munks, J. M. Purkerson, and D. C. Parker. 2000. Resting B lymphocytes as APC for naive T lymphocytes: dependence on CD40 ligand/CD40. J. Immunol. 164:688.
49. Lu, L., W. Li, F. Fu, F. G. Chambers, S. Qian, J. J. Fung, and A. W. Thomson. 1997. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 64:1808.
50. Markees, T. G., N. E. Phillips, R. J. Noelle, L. D. Shultz, J. P. Mordes, D. L. Greiner, and A. A. Rossini. 1997. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Transplantation 64:329.
51. Gould, D. S., and H. Auchincloss Jr. 1999. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol. Today 20:77.
52. Mandelbrot, D. A., Y. Furukawa, A. J. McAdam, S. I. Alexander, P. Libby, R. N. Mitchell, and A. H. Sharpe. 1999. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts. J. Immunol. 163:3753.
53. Foy, T. M., D. M. Shepherd, F. H. Durie, A. Aruffo, J. A. Ledbetter, and R. J. Noelle. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178:1567.
54. Foy, T. M., A. Aruffo, J. Bajorath, J. E. Buhlmann, and R. J. Noelle. 1996. Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol. 14:591.